Virulence profile of strains of Cryptococcus neoformans var. grubii evaluated by experimental infection in BALB/c mice and correlation with exoenzyme activity

References

1. Altman D. G. 1997 Practical Statistics for Medical Research London: Chapman & Hall;
   [Google Scholar]
2. Aoki S., Ito-Kuma S., Nakamura K., Kato J., Ninomiya K., Vidotto V. 1994; Extracellular proteolytic activity of Cryptococcus neoformans . Mycopathologia 128:143–150 [CrossRef]
   [Google Scholar]
3. Baroni F. de A. 2001; Ocorrência de Cryptococcus neoformans em excretas de pombos localizadas em torres de igrejas na cidade do Rio de Janeiro: fatores de virulência e sensibilidade aos antifúngicos . Doctoral thesis Instituto de Ciências Biomédicas da Universidade de São Paulo, São Paulo; Brazil: (in Portuguese
4. Barreto de Oliveira M. T., Boekhout T., Theelen B. & 7 other authors; 2004; Cryptococcus neoformans shows a remarkable genotypic diversity in Brazil. J Clin Microbiol 42:1356–1359 [CrossRef]
   [Google Scholar]
5. Brueske C. H. 1986; Proteolytic activity of a clinical isolate of Cryptococcus neoformans . J Clin Microbiol 23:631–633
   [Google Scholar]
6. Buchanan K. L., Murphy J. W. 1998; What makes Cryptococcus neoformans a pathogen?. Emerg Infect Dis 4:71–83 [CrossRef]
   [Google Scholar]
7. Casadevall A., Perfect J. R. 1998 Cryptococcus neoformans Washington, DC: American Society for Microbiology;
   [Google Scholar]
8. Chen S. C., Muller M., Zhou J. Z., Wright L. C., Sorrel T. C. 1997; Phospholipase activity in Cryptococcus neoformans : a new virulence factor?. J Infect Dis 175:414–420 [CrossRef]
   [Google Scholar]
9. Cox G. M., McDade H. C., Chen S. C. A. & 8 other authors; 2001; Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans . Mol Microbiol 39:166–175 [CrossRef]
   [Google Scholar]
10. Dias A. L. T., Matsumoto F. E., Melhem M. S. C., Costa S. O. P., Sigueria A. M., Paula C. R. 2003; Evaluation of broth microdilution method for susceptibility testing of Brazilian clinical and environmental Cryptococcus neoformans isolates to five antifungal drugs. In Trends in Medical Mycology pp  123–125 Proceedings of the 9th Congress of the European Confederation of Medical Mycology and 7th Trends in Invasive Fungal Infections Amsterdam: 28 September–1 October 2003 Bologna: Monduzzi Editore;
    [Google Scholar]
11. Doering T. L., Nosanchunk J. D., Roberts W. K., Casadevall A. 1999; Melanin as a potential cryptococcal defence against microbicidal proteins. Med Mycol 37:175–181 [CrossRef]
    [Google Scholar]
12. Franzot S. P., Mukherjee J., Cherniak R., Chen L.-C., Hamdan J. S., Casadevall A. 1998; Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect Immun 66:89–97
    [Google Scholar]
13. Franzot S. P., Salkin I. F., Casadevall A. 1999; Cryptococcus neoformans var. grubii : separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol 37:838–840
    [Google Scholar]
14. Ghannoum M. A. 2000; Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 13:122–143 [CrossRef]
    [Google Scholar]
15. Huerfano S., Cepero M. C., Castaneda E. 2003; Phenotype characterization of environmental Cryptococcus neoformans isolates. Biomedica 23:328–340 (in Spanish [CrossRef]
    [Google Scholar]
16. Ikeda R., Shinoda T., Fukazawa Y., Kaufman L. 1982; Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates. J Clin Microbiol 16:22–29
    [Google Scholar]
17. Kurtzman C. P., Fell J. W. (editors) 1998 The Yeasts: a Taxonomic Study New York: Elsevier;
    [Google Scholar]
18. Lacaz C. S., Porto E., Martins J. E. C., Vaccari-Heins E. M., De Melo N. T. 2002; Tratado de Micologia Médica . São Paulo: Sarvier (in Portuguese
    [Google Scholar]
19. Liu L., Wakamatsu K., Ito S., Williamson P. R. 1999; Catecholamine oxidative products, but not melanin, are produced by Cryptococcus neoformans during neuropathogenesis in mice. Infect Immun 67:108–112
    [Google Scholar]
20. Montenegro H., Paula C. R. 2000; Environmental isolation of Cryptococcus neoformans var.gattii and C. neoformans var. neoformans in the city of São Paulo, Brazil. . Med Mycol 38:385–390 [CrossRef]
    [Google Scholar]
21. Noverr M. C., Cox G. M., Perfect J. R., Huffnagle G. B. 2003; Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect Immun 71:1538–1547 [CrossRef]
    [Google Scholar]
22. Noverr M. C., Williamson P. R., Fajardo R. S., Huffnagle G. B. 2004; CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence. Infect Immun 72:1693–1699 [CrossRef]
    [Google Scholar]
23. Olszewski M. A., Noverr M. C., Chen G.-H., Toews G. B., Cox G. M., Perfect J. R., Huffnagle G. B. 2004; Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am J Pathol 164:1761–1771 [CrossRef]
    [Google Scholar]
24. Pappalardo M. C. S. M., Melhem M. S. C. 2003; Cryptococcosis: a review of the Brazilian experience for the disease. Rev Inst Med Trop Sao Paulo 45:299–305
    [Google Scholar]
25. Price M. F., Wilkinson I. D., Gentry L. O. 1982; Plate method for detection of phospholipase activity in Candida albicans . Sabouraudia 20:7–14 [CrossRef]
    [Google Scholar]
26. Ruchel R., Tegeler R., Trost M. 1982; A comparison of secretory proteinases from different strains of Candida albicans . Sabouraudia 20:233–244 [CrossRef]
    [Google Scholar]
27. Santangelo R. T., Nouri-Sorkhabi M. H., Sorrel T. C., Cagney M., Chen S. C., Kuchel P. W., Wright L. C. 1999; Biochemical and functional characterisation of secreted phospholipase activities from Cryptococcus neoformans in their naturally occurring state. J Med Microbiol 48:731–740 [CrossRef]
    [Google Scholar]
28. Santangelo R., Zoellner H., Sorrel T., Wilson C., Donald C., Djordjevic J., Shounan Y., Wright L. 2004; Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model. Infect Immun 72:2229–2239 [CrossRef]
    [Google Scholar]
29. Steenbergen J. N., Casadevall A. 2003; The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans . Microbes Infect 5:667–675 [CrossRef]
    [Google Scholar]
30. Vidotto V., Koga-Ito C. Y., Canella D., Sinicco A., Di Perri G., Aoki S., Ito-Kuwa S. 2000; Extracellular activity in Cryptococcus neoformans strains isolated from AIDS patients and from environmental sources. Rev Iberoam Micol 17:14–19
    [Google Scholar]
31. Vidotto V., Melhem M., Pukinskas S., Aoki S., Carrara C., Pugliese A. 2005; Extracellular enzymatic activity and serotype of Cryptococcus neoformans strains isolated from AIDS patients in Brazil. Rev Iberoam Micol 22:29–33 [CrossRef]
    [Google Scholar]
32. Zhu X., Gibbons J., Garcia-Rivera J., Casadevall A., Williamson P. R. 2001; Laccase of Cryptococcus neoformans is a cell wall-associated virulence factor. Infect Immun 69:5589–5596 [CrossRef]
    [Google Scholar]